MARC details
| 000 -LEADER |
|---|
| fixed length control field |
06804cam a2200229 4500 |
| 001 - CONTROL NUMBER |
|---|
| control field |
9780323445504 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
220107t2017 xxu||||| |||| 00| 0 eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9780323445504 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9780323391542 |
| 041 ## - LANGUAGE CODE |
|---|
| Language code of text/sound track or separate title |
eng |
| 100 ## - MAIN ENTRY--PERSONAL NAME |
|---|
| Personal name |
Nissenson, Allen R. |
| 245 #0 - TITLE STATEMENT |
|---|
| Title |
Handbook of dialysis therapy |
| 250 ## - EDITION STATEMENT |
|---|
| Edition statement |
5th ed. |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) |
|---|
| Place of publication, distribution, etc. |
Philadelphia : |
| Name of publisher, distributor, etc. |
Elsevier, |
| Date of publication, distribution, etc. |
2017 |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
1 online resource (xxii, 1128 pages):illustrations (some color) |
| 505 ## - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
Demographics of the end-stage renal disease patient -- Vascular access for hemodialysis in adults -- Central venous access for hemodialysis -- Noninfectious complications from vascular access -- Infectious complications from vascular access -- Surveillance for arteriovenous access -- Interventional nephrology -- Cannulation of hemodialysis vascular access : science and art -- Peritoneal access devices, placement techniques, and maintenance -- Water treatment equipment for in-center hemodialysis -- Methods and complications of dialyzer reuse -- Dialysate composition -- Safety monitors in hemodialysis -- Methods of hemodialysis anticoagulation -- Home preparation and installation for home hemodialysis -- Peritoneal dialysis cyclers and other mechanical devices -- Selecting a dialyzer : technical and clinical considerations -- Uremic toxicity -- Urea kinetic modeling for guiding hemodialysis therapy in adults -- The dialysis prescription -- Improving outcomes for end-stage renal disease patients : shifting the quality paradigm -- Quality, safety, accountability, and medical director responsibilities -- Initiation of dialysis therapy -- Common clinical problems during hemodialysis -- Arrhythmias in hemodialysis patients -- Prevention and therapeutic management of bleeding in dialysis patients -- Hemofiltration and hemodiafiltration -- Continuous renal replacement therapies for acute kidney injury -- Anticoagulation for continuous renal replacement therapy -- Wearable and implantable renal replacement therapy -- Determination of continuous ambulatory peritoneal dialysis and automated peritoneal dialysis prescriptions -- Peritoneal dialysis solutions -- Lymphatics, peritoneal fluid losses, and peritoneal dialysis -- Abnormalities of host defense mechanisms during peritoneal dialysis -- Peritoneal catheter exit site and tunnel infections -- Peritonitis in peritoneal dialysis patients -- Peritoneal membrane dysfunction : inadequate solute removal, ultrafiltration failure, and encapsulating peritoneal sclerosis -- Abdominal catastrophes, peritoneal eosinophilia, and other unusual events in peritoneal dialysis -- Metabolic effects of peritoneal dialysis -- Abdominal hernias in continuous ambulatory peritoneal dialysis -- Peritoneal dialysate leaks -- Hydrothorax and peritoneal dialysis -- Acid-base homeostasis in dialysis -- Nutritional management of hemodialysis patients -- Intradialytic parenteral nutrition and intraperitoneal nutrition -- Nutritional management in peritoneal dialysis -- Liver disease and gastrointestinal disorders in dialysis patients -- Care of the HIV-infected dialysis patient -- Use of erythropoiesis-stimulating agents in hemodialysis patients -- Anemia in patients with end-stage kidney disease -- Iron use in end-stage renal disease -- Resistance to erythropoiesis-stimulating agent (ESA) treatment -- The challenges of blood pressure control in dialysis patients -- Management of ischemic heart disease, heart failure, and pericarditis in hemodialysis patients -- Avoidance and treatment of cardiovascular disease in dialysis -- Management of dyslipidemia in long-term dialysis patients -- Abnormalities of thyroid function in chronic dialysis patients -- Metabolic abnormalities : evaluation of sexual dysfunction --;Chronic kidney disease-mineral and bone disorder -- Phosphate management in patients with end-stage renal disease -- Use of vitamin D sterols and calcimimetics in patients with end-stage renal disease -- Parathyroidectomy -- Acquired cystic kidney disease -- End-stage renal failure in the diabetic patient -- Principles of drug usage in dialysis patients -- Medication management -- Physical activity, function, and exercise-based rehabilitation for dialysis patients -- Physical, psychosocial, and vocational rehabilitation of adult dialysis patients -- Ethical considerations in the care of dialysis patients -- Psychosocial issues in dialysis patients -- The care of elderly dialysis and end-stage renal disease patients -- Vascular access in children -- Infant hemodialysis -- Urea kinetic modeling for hemodialysis prescription in children -- Hemodiafiltration in children : an ultrapure complete blood purification -- Home hemodialysis in children -- Anticoagulation in children undergoing hemodialysis -- Peritoneal dialysis catheter placement in children -- Prescribing peritoneal dialysis in children -- Nutritional management of children undergoing peritoneal dialysis -- Peritoneal dialysis in neonates and infants -- Dialysis in inborn errors of metabolism -- Neurocognitive functioning in children undergoing dialysis -- Growth in children with end-stage renal disease -- Adequacy of peritoneal dialysis/assessing peritoneal function in pediatric patients -- Continuous renal replacement therapy in pediatric patients -- Prevention and treatment of bone disease in pediatric dialysis patients -- Management of anemia in children undergoing dialysis -- Assessing quality of life in pediatric patients undergoing dialysis -- Immunization in children undergoing dialysis -- Prevention and treatment of cardiovascular complications in children undergoing dialysis -- Surgery in children with end-stage renal disease -- Infectious complications in children undergoing dialysis -- Adherence and transition in the pediatric dialysis patient -- Pregnancy in dialysis patients -- Treatment of poisoning with extracorporeal methods -- Preventive care in end-stage renal disease -- Application of telemedicine to patients with end-stage renal disease. |
| 520 ## - SUMMARY, ETC. |
|---|
| Summary, etc. |
Providing practical, immediately useful guidelines that can be applied directly to patient care, Handbook of Dialysis Therapy is a must-have resource for all dialysis caregivers. This new edition has been updated with the latest cutting-edge technology, dialysis techniques, and complications related to various diseases for both pediatric and adult patients. In-depth yet concise, it explains complex dialysis concepts through abundant diagrams, photos, line drawings, and tables, while its readable hands-on approach allows for quick review of key information. |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) |
|---|
| Topical term or geographic name as entry element |
Hemodialysis. |
| 700 ## - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Fine, Richard N. |
| 856 ## - ELECTRONIC LOCATION AND ACCESS |
|---|
| Uniform Resource Identifier |
<a href="https://go.openathens.net/redirector/nhs?url=https://www.clinicalkey.com/dura/browse/bookChapter/3-s2.0-C20140031723">https://go.openathens.net/redirector/nhs?url=https://www.clinicalkey.com/dura/browse/bookChapter/3-s2.0-C20140031723</a> |